Most researchers don't understand statistical significance. So, marketers -- and planners and buyers -- can be forgiven for ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend ...

IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's progression in a late-stage study, but narrowly missed the main goal as the results ...